We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Ease of Use Study for the Gambro Polyflux HD-C4 Small Dialyzer

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00579202
First Posted: December 21, 2007
Last Update Posted: April 5, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Gambro Renal Products, Inc.
Information provided by (Responsible Party):
Baxter Healthcare Corporation
December 19, 2007
December 21, 2007
April 5, 2017
October 2007
November 2007   (Final data collection date for primary outcome measure)
For each dialyzer, the perceived ease of priming. [ Time Frame: During priming of each dialyzer ]
Same as current
Complete list of historical versions of study NCT00579202 on ClinicalTrials.gov Archive Site
Visual assessment of residual blood in the dialyzer after rinse-back and if dialyzer clotted during treatment. [ Time Frame: At the completion of each treatment ]
Same as current
Not Provided
Not Provided
 
Ease of Use Study for the Gambro Polyflux HD-C4 Small Dialyzer
The Gambro Polyflux HD-C4 Small Ease of Use Study
The purpose of the study is to study the ease of use of the Polyflux HD-C4 Small dialyzer under conditions of routine clinical use for hemodialysis

Market evaluation protocol.

This ease of use study involves the use of FDA 510(k) cleared hemodialyzers and will have no impact on the patient's routine dialysis therapy. This study is strictly aimed at obtaining feedback from the nursing and technical staff regarding the use of the Polyflux HD-C4 Small dialyzer. The dialysis nursing staff will complete ease of use assessments following routine dialysis therapy.

Observational
Observational Model: Other
Time Perspective: Other
Not Provided
Not Provided
Non-Probability Sample
The dialysis nursing staff will complete ease of use assessments following routine dialysis therapy of adult (≥ 18 years of age) patients
Hemodialysis
Device: Gambro HD-C4 Small Dialyzer
Involves the use of FDA 510(k) cleared hemodialyzers and will have no impact on the patient's routine dialysis therapy.
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
24
November 2007
November 2007   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • n/a routine dialysis patients

Exclusion Criteria:

  • n/a routine dialysis patients
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT00579202
07-0002
No
Not Provided
Not Provided
Baxter Healthcare Corporation
Baxter Healthcare Corporation
Gambro Renal Products, Inc.
Principal Investigator: Rana Irmindra, M.D. Advanced Dialysis Center
Baxter Healthcare Corporation
April 2017